232 related articles for article (PubMed ID: 28159817)
1. Tissue Transglutaminase Modulates Vascular Stiffness and Function Through Crosslinking-Dependent and Crosslinking-Independent Functions.
Steppan J; Bergman Y; Viegas K; Armstrong D; Tan S; Wang H; Melucci S; Hori D; Park SY; Barreto SF; Isak A; Jandu S; Flavahan N; Butlin M; An SS; Avolio A; Berkowitz DE; Halushka MK; Santhanam L
J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28159817
[TBL] [Abstract][Full Text] [Related]
2. Increased tissue transglutaminase activity contributes to central vascular stiffness in eNOS knockout mice.
Jung SM; Jandu S; Steppan J; Belkin A; An SS; Pak A; Choi EY; Nyhan D; Butlin M; Viegas K; Avolio A; Berkowitz DE; Santhanam L
Am J Physiol Heart Circ Physiol; 2013 Sep; 305(6):H803-10. PubMed ID: 23873798
[TBL] [Abstract][Full Text] [Related]
3. Transglutaminase 2 is central to induction of the arterial calcification program by smooth muscle cells.
Johnson KA; Polewski M; Terkeltaub RA
Circ Res; 2008 Mar; 102(5):529-37. PubMed ID: 18202319
[TBL] [Abstract][Full Text] [Related]
4. Cystamine reduces vascular stiffness in Western diet-fed female mice.
Ramirez-Perez FI; Cabral-Amador FJ; Whaley-Connell AT; Aroor AR; Morales-Quinones M; Woodford ML; Ghiarone T; Ferreira-Santos L; Jurrissen TJ; Manrique-Acevedo CM; Jia G; DeMarco VG; Padilla J; Martinez-Lemus LA; Lastra G
Am J Physiol Heart Circ Physiol; 2022 Feb; 322(2):H167-H180. PubMed ID: 34890280
[TBL] [Abstract][Full Text] [Related]
5. Vena cava and aortic smooth muscle cells express transglutaminases 1 and 4 in addition to transglutaminase 2.
Johnson KB; Petersen-Jones H; Thompson JM; Hitomi K; Itoh M; Bakker EN; Johnson GV; Colak G; Watts SW
Am J Physiol Heart Circ Physiol; 2012 Apr; 302(7):H1355-66. PubMed ID: 22307675
[TBL] [Abstract][Full Text] [Related]
6. Exercise, vascular stiffness, and tissue transglutaminase.
Steppan J; Sikka G; Jandu S; Barodka V; Halushka MK; Flavahan NA; Belkin AM; Nyhan D; Butlin M; Avolio A; Berkowitz DE; Santhanam L
J Am Heart Assoc; 2014 Apr; 3(2):e000599. PubMed ID: 24721796
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of transglutaminase-2 prevents early age-induced vascular changes in mice1.
Armstrong DMF; Sikka G; Armstrong ADC; Saad KR; Freitas WR; Berkowitz DE; Fagundes DJ; Santhanam L; Taha MO
Acta Cir Bras; 2018 Nov; 33(11):991-999. PubMed ID: 30517326
[TBL] [Abstract][Full Text] [Related]
8. Transglutaminase activity is decreased in large arteries from hypertensive rats compared with normotensive controls.
Petersen-Jones HG; Johnson KB; Hitomi K; Tykocki NR; Thompson JM; Watts SW
Am J Physiol Heart Circ Physiol; 2015 Mar; 308(6):H592-602. PubMed ID: 25599570
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms involved in extracellular matrix remodeling and arterial stiffness induced by hyaluronan accumulation.
Lorentzen KA; Chai S; Chen H; Danielsen CC; Simonsen U; Wogensen L
Atherosclerosis; 2016 Jan; 244():195-203. PubMed ID: 26671518
[TBL] [Abstract][Full Text] [Related]
10. Transglutaminase 2 promotes PDGF-mediated activation of PDGFR/Akt1 and β-catenin signaling in vascular smooth muscle cells and supports neointima formation.
Nurminskaya M; Beazley KE; Smith EP; Belkin AM
J Vasc Res; 2014; 51(6):418-28. PubMed ID: 25612735
[TBL] [Abstract][Full Text] [Related]
11. Vascular smooth muscle cells remodel collagen matrices by long-distance action and anisotropic interaction.
van den Akker J; Tuna BG; Pistea A; Sleutel AJ; Bakker EN; van Bavel E
Med Biol Eng Comput; 2012 Jul; 50(7):701-15. PubMed ID: 22674440
[TBL] [Abstract][Full Text] [Related]
12. Tissue transglutaminase does not affect fibrotic matrix stability or regression of liver fibrosis in mice.
Popov Y; Sverdlov DY; Sharma AK; Bhaskar KR; Li S; Freitag TL; Lee J; Dieterich W; Melino G; Schuppan D
Gastroenterology; 2011 May; 140(5):1642-52. PubMed ID: 21277850
[TBL] [Abstract][Full Text] [Related]
13. Lysyl oxidase-like 2 depletion is protective in age-associated vascular stiffening.
Steppan J; Wang H; Bergman Y; Rauer MJ; Tan S; Jandu S; Nandakumar K; Barreto-Ortiz S; Cole RN; Boronina TN; Zhu W; Halushka MK; An SS; Berkowitz DE; Santhanam L
Am J Physiol Heart Circ Physiol; 2019 Jul; 317(1):H49-H59. PubMed ID: 31002285
[TBL] [Abstract][Full Text] [Related]
14. Crosslinking and G-protein functions of transglutaminase 2 contribute differentially to fibroblast wound healing responses.
Stephens P; Grenard P; Aeschlimann P; Langley M; Blain E; Errington R; Kipling D; Thomas D; Aeschlimann D
J Cell Sci; 2004 Jul; 117(Pt 15):3389-403. PubMed ID: 15199098
[TBL] [Abstract][Full Text] [Related]
15. A novel extracellular role for tissue transglutaminase in matrix-bound VEGF-mediated angiogenesis.
Wang Z; Perez M; Caja S; Melino G; Johnson TS; Lindfors K; Griffin M
Cell Death Dis; 2013 Sep; 4(9):e808. PubMed ID: 24052076
[TBL] [Abstract][Full Text] [Related]
16. Probing tissue transglutaminase mediated vascular smooth muscle cell aging using a novel transamidation-deficient Tgm2-C277S mouse model.
Wang H; Chen J; Jandu S; Melucci S; Savage W; Nandakumar K; Kang SK; Barreto-Ortiz S; Poe A; Rastogi S; Bauer M; Steppan J; Santhanam L
Cell Death Discov; 2021 Jul; 7(1):197. PubMed ID: 34326316
[TBL] [Abstract][Full Text] [Related]
17. The treatment of collagen fibrils by tissue transglutaminase to promote vascular smooth muscle cell contractile signaling.
Spurlin TA; Bhadriraju K; Chung KH; Tona A; Plant AL
Biomaterials; 2009 Oct; 30(29):5486-96. PubMed ID: 19640581
[TBL] [Abstract][Full Text] [Related]
18. Mechanical behavior and matrisome gene expression in the aneurysm-prone thoracic aorta of newborn lysyl oxidase knockout mice.
Staiculescu MC; Kim J; Mecham RP; Wagenseil JE
Am J Physiol Heart Circ Physiol; 2017 Aug; 313(2):H446-H456. PubMed ID: 28550176
[TBL] [Abstract][Full Text] [Related]
19. Role of hypoxia-induced transglutaminase 2 in pulmonary artery smooth muscle cell proliferation.
Penumatsa KC; Toksoz D; Warburton RR; Hilmer AJ; Liu T; Khosla C; Comhair SA; Fanburg BL
Am J Physiol Lung Cell Mol Physiol; 2014 Oct; 307(7):L576-85. PubMed ID: 25128524
[TBL] [Abstract][Full Text] [Related]
20. Implications of enigmatic transglutaminase 2 (TG2) in cardiac diseases and therapeutic developments.
Al-U'datt DGF; Tranchant CC; Al-Dwairi A; Alqudah M; Al-Shboul O; Hiram R; Allen BG; Jaradat S; Alqbelat J; Abu-Zaiton AS
Biochem Pharmacol; 2022 Jul; 201():115104. PubMed ID: 35617996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
